Coherus Biosciences | CHRS - 보통주 자본





보통주 자본 변화 날짜
AbbVie USD 1.77B 1.75B 2025-06
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Akebia Therapeutics USD 265.42M 199K 2025-12
ALKERMES USD 165.61M 503K 2025-12
Alnylam Pharmaceuticals USD 133.44M 1.07M 2026-03
Amarin USD 20.81M 13K 2025-12
Amgen USD 540M 1000K 2026-03
Baxter International USD 516.45M 2.17M 2026-03
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.27M 969K 2026-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Coherus Biosciences USD 121.16M 4.92M 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
Fujifilm JPY 1.21B 19K 2025-12
Gilead Sciences USD 1.24B 1000K 2025-12
Ironwood Pharmaceuticals USD 160K 0 2024-12
Merck USD 2.47B 12.72M 2025-12
Myriad Genetics USD 93.5M 400K 2025-12
Pacira USD 39.31M 1.81M 2026-03
Perrigo USD 137.6M 0 2025-12
Pfizer USD 5.69B 0 2025-12
PTC Therapeutics USD 81.47M 1.54M 2025-12
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Sarepta Therapeutics USD 104.96M 196K 2025-12
Teva Pharmaceutical Industries USD 1.16B 16.72M 2026-03
Vertex Pharmaceuticals USD 254.2M 200K 2026-03
Xencor USD 71.87M 529K 2025-12
Zoetis USD 424.93M 16.54M 2025-12